Impact of Vaccine Awareness Campaigns on Pharmacovigilance Reporting and Public Safety Monitoring

Year : 2026 | Volume : 03 | Issue : 02 | Page : 1 14
    By

    Suraj Sen,

  • Anit Jha,

  • Priyanshu Upadhyay,

  • Rohit,

  • Aman Kumar,

  • Arvind Bhardwaj,

  1. Principal, Dept. of Pharmacy, Harishchandra Pharmacy College, Jaunpur , U.P., India
  2. Academic Head, Dept. of Pharmacy, Harishchandra Pharmacy College, Jaunpur , U.P., India
  3. Lecturer, Dept. of Pharmacy, Harishchandra Pharmacy College, Jaunpur , U.P., India
  4. Scholar, Dept. of Pharmacy, Harishchandra Pharmacy College, Jaunpur , U.P., India
  5. Scholar, Dept. of Pharmacy, Harishchandra Pharmacy College, Jaunpur , U.P., India
  6. Scholar, Dept. of Pharmacy, Harishchandra Pharmacy College, Jaunpur , U.P., India

Abstract

Vaccination programs have significantly contributed to the reduction of infectious diseases worldwide; however, their success is closely tied to public confidence and robust safety monitoring systems. Pharmacovigilance plays a critical role in identifying, assessing, and preventing adverse events following immunization (AEFI). In recent years, vaccine awareness campaigns have emerged as a pivotal strategy to improve public knowledge, reduce vaccine hesitancy, and enhance reporting of adverse drug reactions (ADRs). This review explores the impact of vaccine awareness campaigns on pharmacovigilance reporting systems and overall public safety monitoring. It evaluates how educational interventions, media campaigns, and healthcare professional engagement influence reporting rates, data quality, and early detection of safety signals. Additionally, the article discusses global pharmacovigilance frameworks, reporting barriers, digital innovations, and the integration of awareness initiatives into surveillance systems. The findings suggest that awareness campaigns significantly improve spontaneous reporting rates, patient engagement, and transparency in vaccine safety monitoring. However, challenges, such as misinformation, underreporting, and variability in campaign effectiveness, persist. Strengthening communication strategies, integrating digital reporting tools, and fostering community trust are essential for optimizing pharmacovigilance outcomes.

Keywords: Vaccine awareness, pharmacovigilance, adverse drug reaction (ADR), public safety monitoring, AEFI, vaccine hesitancy, drug surveillance, health communication, immunization programs, reporting systems

[This article belongs to International Journal of Vaccines ]

How to cite this article:
Suraj Sen, Anit Jha, Priyanshu Upadhyay, Rohit, Aman Kumar, Arvind Bhardwaj. Impact of Vaccine Awareness Campaigns on Pharmacovigilance Reporting and Public Safety Monitoring. International Journal of Vaccines. 2026; 03(02):1-14.
How to cite this URL:
Suraj Sen, Anit Jha, Priyanshu Upadhyay, Rohit, Aman Kumar, Arvind Bhardwaj. Impact of Vaccine Awareness Campaigns on Pharmacovigilance Reporting and Public Safety Monitoring. International Journal of Vaccines. 2026; 03(02):1-14. Available from: https://journals.stmjournals.com/ijv/article=2026/view=244430


References

1. World Health Organization. Global vaccine safety blueprint 2.0 (GVSB2.0) 2021–2023.
2. Pharmacovigilance WH. Ensuring the safe use of medicines. WHO policy perspective of medicine.
Geneva: WHO; 2004.
3. World Health Organization. The importance of pharmacovigilance.
4. Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the vaccine adverse
event reporting system (VAERS). Vaccine. 2015 Aug 26;33(36):4398–405.
5. Castellana E, Budau PM, Chiappetta MR. Pharmacovigilance: Overview of Italian and European
regulations, tools, and perspectives. Int J Risk Saf Med. 2025 Nov;36(4):147–55.
6. Jadaun GP, Rastogi S, Kumar A, Chauhan J, Sharma SK, Kumar M, et al. Ensuring the quality of
medicines in India: An update on the development, modernization, and harmonization of drug
standards in the Indian Pharmacopoeia. Saudi Pharm J. 2023 Dec 1;31(12):101825.
7. Hazell L, Shakir SA. Under-reporting of adverse drug reactions. Drug Saf. 2006 May;29(5):385–96.
8. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug
reactions: A systematic review. Drug Saf. 2009 Jan;32(1):19–31.
9. Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around
vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–
2012. Vaccine. 2014 Apr 17;32(19):2150–9.
10. Betsch C, Böhm R, Chapman GB. Using behavioral insights to increase vaccination policy
effectiveness. Policy Insights Behav Brain Sci. 2015 Oct;2(1):61–73.
11. World Health Organization. COVID-19 vaccines: Safety surveillance manual. Geneva: World
Health Organization; 2020 Dec 22.
12. Black S, Eskola J, Siegrist CA, Halsey N, MacDonald N, Law B, et al. Importance of background
rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1
influenza vaccines. Lancet. 2009 Dec 19;374(9707):2115–22.
13. Gagne JJ, Maio V, Rabinowitz C. Prevalence and predictors of potential drug–drug interactions in
Regione Emilia‐Romagna, Italy. J Clin Pharm Ther. 2008 Apr;33(2):141–51.
14. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet.
2000 Oct 7;356(9237):1255–9.
15. Pal SN, Duncombe C, Falzon D, Olsson S. WHO strategy for collecting safety data in public health
programmes: Complementing spontaneous reporting systems. Drug Saf. 2013 Feb;36(2):75–81.
16. Freifeld CC, Brownstein JS, Menone CM, Bao W, Filice R, Kass-Hout T, et al. Digital drug safety
surveillance: Monitoring pharmaceutical products in twitter. Drug Saf. 2014 May;37(5):343–50.
17. Salathé M, Khandelwal S. Assessing vaccination sentiments with online social media: Implications
for infectious disease dynamics and control. PLoS Comput Biol. 2011 Oct 13;7(10):e1002199.
18. Wilson K, Atkinson K, Deeks S. Opportunities for utilizing new technologies to increase vaccine
confidence. Expert Rev Vaccines. 2014 Aug 1;13(8):969–77.
19. Orenstein WA, Ahmed R. Simply put: Vaccination saves lives. Proc Natl Acad Sci U S A. 2017
Apr 18;114(16):4031–3.
20. Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug
Saf. 1999 Feb;20(2):109–17.

Regular Issue Subscription Review Article
Volume 03
Issue 02
Received 04/05/2026
Accepted 07/05/2026
Published 20/05/2026
Publication Time 16 Days
17

Login


My IP

PlumX Metrics